 |
市場調查報告書
商品編碼
1567232
慢性病管理市場：按疾病類型、按服務類型、按交付方式、按最終用戶、按地區Chronic Disease Management Market, By Disease Type, By Service Type, By Delivery Mode, By End User, By Geography |
||||||
預計2024年全球慢性病管理市場規模為57.1億美元，2031年將達138億美元，2024年至2031年複合年成長率為13.4%。
| 報告範圍 | 報告詳情 | ||
|---|---|---|---|
| 基準年 | 2023年 | 2024年市場規模 | 57.1億美元 |
| 實際資料 | 2019-2023 | 預測期 | 2024年至2031年 |
| 預測 2024-2031 年複合年成長率： | 13.40% | 2031年價值預測 | 138億美元 |
糖尿病、癌症、心血管疾病 (CVD)、慢性阻塞性肺病(COPD) 和氣喘等慢性疾病是需要持續醫療照護並限制日常生活的長期健康狀況。其中大多數可以透過改變生活方式來預防，例如避免吸煙和保持健康的體重。然而，繁忙的日程和緊張的生活使這些症狀難以控制。這增加了對更好的慢性病管理技術的需求。遠端患者監護方面的各種技術進步以及政府改善醫療基礎設施的努力可能會在不久的將來推動市場成長。
市場動態：
全球慢性病管理市場的成長是由患有多種慢性病的老年人口增加、肥胖和飲食習慣改變導致的糖尿病和心血管疾病等與文明病率增加以及早期發現推動的這是由於人們對醫療保健和疾病管理的好處的認知不斷提高、數位醫療解決方案的技術進步以及各國政府和私營組織為遏制醫療成本上漲而做出的努力等因素推動的。然而，對資料隱私的擔憂、實施遠端監控設備和服務的高成本以及開發中國家缺乏熟練的醫療保健專業人員可能會阻礙更快的採用。開拓的管理多種疾病的綜合平台、擴大人工智慧和穿戴式技術的作用以及日益關注個性化護理，為市場參與者提供了利潤豐厚的成長機會。
本研究的主要特點
該報告對全球慢性病管理市場進行了詳細分析，以2023年為基準年估計了預測期（2024-2031年）的市場規模（十億美元）和年複合成長率（CAGR%）。
它還揭示了各個細分市場的潛在商機，並說明了該市場有吸引力的投資提案矩陣。
它還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景、主要企業採取的競爭策略等的重要見解。
根據公司亮點、產品系列、主要亮點、績效和策略等參數對全球慢性病管理市場的主要企業進行了分析。
本研究涵蓋的主要企業包括 IBM、Cerner Corporation、Epic Systems、McKesson Corporation、Athenahealth、Healthagen、Allscripts、Optum（UnitedHealth Group 的一部分）、Conifer Health Solutions、NXGN Management、Phytel、I2I Population Health 和 Includes Healthwise。
該報告的見解使負責人和公司經營團隊能夠就未來的產品發布、升級、市場擴張和行銷策略做出明智的決策。
全球慢性病管理市場報告迎合了該行業的各種相關人員，如投資者、供應商、產品製造商、經銷商、新進業者和財務分析師。
透過用於分析全球慢性病管理市場的各種策略矩陣，將有助於相關人員做出決策。
目錄
第1章 研究目的與前提
- 研究目的
- 先決條件
- 簡稱
第2章 市場展望
- 報告說明
- 市場定義和範圍
- 執行摘要
第3章市場動態、法規及趨勢分析
- 市場動態
- 促進因素
- 抑制因素
- 機會
- 影響分析
- 市場趨勢
- 主要進展
- 監管場景
- 收購和合作場景
- 資金籌措和投資
- PEST分析
- 波特的分析
第4章全球慢性病管理市場－冠狀病毒（COVID-19）大流行的影響
- 整體影響
- 政府舉措
- COVID-19 對市場的影響
第5章全球慢性病管理市場，依疾病類型，2019-2031（十億美元）
- 心血管疾病
- 糖尿病
- 呼吸系統疾病
- 癌症
- 慢性腎臟病
- 其他
第6章 全球慢性病管理市場，依服務類型，2019-2031 年（十億美元）
- 疾病管理計劃
- 遠端患者監護
- 遠端醫療服務
- 其他
第7章 全球慢性病管理市場，以交付方式，2019-2031 年（十億美元）
- 本地
- 基於網路的
- 雲端基礎
第 8 章 全球慢性病管理市場，依最終用戶分類，2019-2031 年（十億美元）
- 醫院
- 專科診所
- 家庭護理設置
- 其他
第9章全球慢性病管理市場，按地區，2019-2031，（十億美元）
- 北美洲
- 拉丁美洲
- 歐洲
- 亞太地區
- 中東
- 非洲
第10章競爭格局
- 公司簡介
- UnitedHealth Group
- CVS Health
- Cigna
- Anthem, Inc.
- Aetna（a CVS Health company）
- Mayo Clinic
- Kaiser Permanente
- Humana Inc.
- Teladoc Health, Inc.
- McKesson Corporation
- Cerner Corporation
- Epic Systems Corporation
- Medtronic
- Abbott Laboratories
- Novartis AG
- Roche Holding AG
- Bristol-Myers Squibb
- Johns Hopkins Medicine
- GE Healthcare
- Philips Healthcare
第11章分析師建議
- 命運之輪
- 分析師觀點
- 一致的機會圖
第12章參考文獻與調查方法
- 參考
- 調查方法
Global chronic disease management market is estimated to be valued at USD 5.71 Bn in 2024 and is expected to reach USD 13.80 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 13.4% from 2024 to 2031.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2023 | Market Size in 2024: | US$ 5.71 Bn |
| Historical Data for: | 2019 to 2023 | Forecast Period: | 2024 to 2031 |
| Forecast Period 2024 to 2031 CAGR: | 13.40% | 2031 Value Projection: | US$ 13.80 Bn |
Chronic diseases, such as diabetes, cancer, cardiovascular diseases (CVD), chronic obstructive pulmonary disease (COPD), and asthma are long-term health conditions that require ongoing medical care and limit daily activities. These are largely preventable through lifestyle changes, like avoiding tobacco and maintaining healthy weight. However, busy schedules and stressful lives have made managing such conditions challenging. This has boosted demand for better chronic disease management techniques. Various technological advancements in remote patient monitoring and growing efforts by governments to improve healthcare infrastructure can drive the market growth in the near future.
Market Dynamics:
Global chronic disease management market growth is driven by factors like growing geriatric population burdened by multiple chronic conditions, increasing incidence of lifestyle diseases such as diabetes and cardiovascular diseases due to obesity and changing dietary patterns, growing awareness about benefits of early disease detection and disease management, technological advances in digital health solutions, and initiatives by various governments and private organizations to curb rising healthcare costs. However, data privacy concerns, high deployment costs of remote monitoring devices and services, and lack of skilled healthcare professionals in developing nations can hamper faster adoption. Development of integrated platforms to manage multiple conditions, expanding role of AI and wearable technologies, and growing focus on personalized care provide lucrative growth opportunities for market players.
Key features of the study:
This report provides in-depth analysis of the global chronic disease management market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global chronic disease management market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include IBM, Cerner Corporation, Epic Systems, McKesson Corporation, Athenahealth, Healthagen, Allscripts, Optum (A Part of UnitedHealth Group), Conifer Health Solutions, NXGN Management, Phytel, I2I Population Health, and Healthwise
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Global chronic disease management market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global chronic disease management market
Detailed Segmentation-
- Disease Type Insights (Revenue, USD Bn, 2019 - 2031)
- Cardiovascular Diseases
- Diabetes
- Respiratory Diseases
- Cancer
- Chronic Kidney Disease
- Others (Arthritis, etc.)
- Service Type Insights (Revenue, USD Bn, 2019 - 2031)
- Disease Management Programs
- Remote Patient Monitoring
- Telehealth Services
- Others (Diagnostic Services, etc.)
- Delivery Mode Insights (Revenue, USD Bn, 2019 - 2031)
- On-premise
- Web-based
- Cloud-based
- End User Insights (Revenue, USD Bn, 2019 - 2031)
- Hospitals
- Specialty Clinics
- Home Care Settings
- Others (Pharmaceutical Companies, etc.)
- Regional Insights (Revenue, USD Bn 2019 - 2031)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- UnitedHealth Group
- CVS Health
- Cigna
- Anthem, Inc.
- Aetna (a CVS Health company)
- Mayo Clinic
- Kaiser Permanente
- Humana Inc.
- Teladoc Health, Inc.
- McKesson Corporation
- Cerner Corporation
- Epic Systems Corporation
- Medtronic
- Abbott Laboratories
- Novartis AG
- Roche Holding AG
- Bristol-Myers Squibb
- Johns Hopkins Medicine
- GE Healthcare
- Philips Healthcare
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Disease Type
- Market Snapshot, By Service Type
- Market Snapshot, By Delivery Mode
- Market Snapshot, By End User
- Market Snapshot, By Region
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Opportunities
- Impact Analysis
- Market Trends
- Key Developments
- Regulatory Scenario
- Acquisitions and Partnerships Scenario
- Funding and Investments
- PEST Analysis
- Porter's Analysis
4. Global Chronic Disease Management Market - Impact of Coronavirus (COVID-19) Pandemic
- Overall Impact
- Government Initiatives
- COVID-19 Impact on the Market
5. Global Chronic Disease Management Market, By Disease Type, 2019 - 2031, (USD Bn)
- Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
- Cardiovascular Diseases
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Diabetes
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Respiratory Diseases
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Cancer
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Chronic Kidney Disease
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
6. Global Chronic Disease Management Market, By Service Type, 2019 - 2031, (USD Bn)
- Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
- Disease Management Programs
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Remote Patient Monitoring
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Telehealth Services
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
7. Global Chronic Disease Management Market, By Delivery Mode, 2019 - 2031, (USD Bn)
- Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
- On-premise
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Web-based
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Cloud-based
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
8. Global Chronic Disease Management Market, By End User, 2019 - 2031, (USD Bn)
- Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
- Hospitals
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Specialty Clinics
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Home Care Settings
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
9. Global Chronic Disease Management Market, By Region, 2019 - 2031, (USD Bn)
- Introduction
- Market Share Analysis, By Region, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, For Region, 2020-2031
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Delivery Mode, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Delivery Mode, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Delivery Mode, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Delivery Mode, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Delivery Mode, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Delivery Mode, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019 - 2031, (USD Bn)
- North Africa
- Central Africa
- South Africa
10. Competitive Landscape
- Company Profiles
- UnitedHealth Group
- Company Highlights
- Method Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- CVS Health
- Cigna
- Anthem, Inc.
- Aetna (a CVS Health company)
- Mayo Clinic
- Kaiser Permanente
- Humana Inc.
- Teladoc Health, Inc.
- McKesson Corporation
- Cerner Corporation
- Epic Systems Corporation
- Medtronic
- Abbott Laboratories
- Novartis AG
- Roche Holding AG
- Bristol-Myers Squibb
- Johns Hopkins Medicine
- GE Healthcare
- Philips Healthcare
- UnitedHealth Group
11. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
12. References and Research Methodology
- References
- Research Methodology
- About us and Sales Contact
